AgelessRx Research
Results of the AgelessRx PEARL Trial: An Expert Analysis
Discover the results of the PEARL trial, straight from the AgelessRx experts who led the study, and learn what this means for the future of…
Could LDN and NAD+ Offer Hope for Long COVID?
Our experts launched a study to determine the effects of Low Dose Naltrexone and NAD+ on Long COVID. The results could move us closer to…
AgelessRx Donates to Support Biology of Aging Research
Learn about AgelessRx's gift to the Michigan Medicine Division of Geriatric and Palliative Medicine Geriatrics Center.
PEARL Webinar Series: A Must-Watch Outlining Our Clinical Study
Check out this video webinar series about a new AgelessRx sponsored study on the use of Rapamycin in longevity treatment.
PEARL and Post-COVID Research Updates
AgelessRx is fully committed to longevity research. Check out a quick update on our two ongoing research projects, PEARL and Post-COVID.
A Quick Update on PEARL, AgelessRx’s Upcoming Clinical Trial
AgelessRx has started recruiting participants to our clinical trial PEARL (Participatory Evaluation of Aging with Rapamycin for Longevity).
AgelessRx Launches Pilot Post-COVID Clinical Trial
Former ARX CMO Dr. Zalzala introduces new post-COVID-19 pilot study and shares how LDN and NAD+ may help with post-COVID-19 Syndrome.
Discover PEARL, Rapamycin & The Aging Process
Discover the science behind Rapamycin and how it impacts the aging process, and PEARL, the first human clinical study for Rapamycin.